Grafiek agenda TCR2 Therapeutics Inc.
Komende gebeurtenissen op TCR2 Therapeutics Inc.
Gebeurtenissen op naam
30-05-2023 14:00 | Buitengewone vergadering - M&A Vote |
11-05-2023 12:30 | Q1 2023 Cijferpublicaties |
23-03-2023 11:30 | Q4 2022 Cijferpublicaties |
14-02-2023 19:00 | SVB Securities Global Biopharma Conference |
29-11-2022 20:00 | Piper Sandler Healthcare Conference |
15-11-2022 18:35 | Jefferies London Healthcare Conference |
08-11-2022 12:45 | Q3 2022 Cijferpublicaties |
07-11-2022 17:40 | Society for Immunotherapy of Cancer Conference - Abstract Number: 219 |
14-10-2022 | Algemene vergadering |
29-09-2022 20:00 | Jefferies Cell and Genetic Medicine Summit |
28-09-2022 14:00 | Gavo-cel Phase 1 Trial Results Call |
10-08-2022 | Wedbush PacGrow Healthcare Conference |
08-08-2022 12:45 | Eerste halfjaar 2022 Cijferpublicaties |
27-06-2022 18:00 | Truist Securities Life Sciences Symposia-cel Conference |
08-06-2022 20:00 | Jefferies Healthcare Conference |
24-05-2022 13:00 | H.C. Wainwright Global Life Sciences Investment Conference |
12-05-2022 12:45 | Q1 2022 Cijferpublicaties |
10-04-2022 20:30 | American Association of Cancer Research Meeting - Poster: 4716 |
22-03-2022 11:45 | Boekjaar 2021 Cijferpublicaties |
16-02-2022 19:40 | SVB Leerink Global Healthcare Conference |
Gebeurtenissen in het verleden in de sector TCR2 Therapeutics Inc.
28-03-2024 21:28 | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Cijferpublicaties |
28-03-2024 21:05 | ARRIVENT BIOPHARMA, INC.: Q4 2023 Cijferpublicaties |
28-03-2024 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Cijferpublicaties (schatting) |
28-03-2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Cijferpublicaties |
28-03-2024 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Cijferpublicaties |
28-03-2024 | ALPHAMAB ONCOLOGY: Q4 2023 Cijferpublicaties |
27-03-2024 | PHARMARON BEIJING CO., LTD.: Q4 2023 Cijferpublicaties |
26-03-2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q4 2023 Cijferpublicaties |
26-03-2024 21:01 | KORRO BIO, INC.: Q4 2023 Cijferpublicaties |
26-03-2024 11:00 | GYRE THERAPEUTICS, INC.: Q4 2023 Cijferpublicaties |